Partnerships

Current Partners

Riken Institute, Japan

Riken LogoQBRI is negotiating an agreement with RIKEN that calls for establishing a joint Omics Science Center with QBRI in Doha. Additionally, the partnership calls for RIKEN to train scientists in the area of breast cancer genomics utilizing RIKEN’s Cap Analysis of Gene Expression (CAGE) transcriptomic technology.

The RIKEN-PMI collaboration will include a joint research laboratory for molecular diagnostics in Qatar, which will enable researchers to discover new biomarkers and develop personalized preventive medical solutions. The partnership’s first project will focus on breast cancer, the most common form of cancer in Qatar, and will be conducted in collaboration with researchers from Hamad Medical Corporation (HMC). QBRI and RIKEN‐PMI will address the possibility of implementing the biomarker discovery project utilizing RIKEN’s genomic technology to identify disease signatures. RIKEN‐PMI will also train QBRI scientists and facilitate the transfer of genomics technologies and expertise in transcription network analysis. Researchers will apply these skills to diagnostics and precision medicine to address health issues that prevail among the Qatari population.

QBRI and RIKEN are discussing organizing a workshop in the bioinformatics area to be conducted in 2015.

Hamad Medical Corporation

Hamad Medical CorporationThe Hamad Medical Corporation (HMC) ethos is based on three key pillars: Health, Education and Research, which signify the organization’s commitment to providing high quality healthcare, the training and education of healthcare professionals, and research that develops evidence-based medicine. Therefore, the strategic partnership between HMC and QBRI is essential to translate findings and innovations from the basic and translational research programs into novel diagnostic, preventive and therapeutic strategies that will improve quality of healthcare for the people in Qatar and the region.

QBRI and HMC are in the process of finalizing and executing an MoU that is a platform for scientific exchange, rich and productive research interactions and truly facilitates translational medicine. QBRI and HMC diabetes and cancer research groups are engaged in collaborative projects on type II diabetes and breast cancer

Qatar University

Qatar UniversityRecently, Qatar Foundation and Qatar University (QU) executed an MoU that establishes an interdisciplinary Ph.D. program (See the News Article). QBRI and QU are implementing strategies to forge a long, lasting strategic partnership predicated on mutual benefit to involved parties. For instance, QBRI is collaborating with the QU’s Health Sciences Department – Biomedical Sciences Program on Ph.D. program and curriculum development. QBRI and QU are in the process of finalizing an agreement on joint education, training and professional development programs including cross-appointments and activity sponsorship.

QU operates the Laboratory Animal Research Centre (LARC), which is the first of its kind in Qatar and offers unique opportunities for scientist, faculty and research students to utilize laboratory animals as valuable tools to study biological processes, elucidate disease mechanisms and test new treatments and therapies.

Sidra Medical Research Center

Sidra logoBoth QBRI and Sidra share a commitment for education/training and translational and clinical biomedical research. Recently, QBRI and SIDRA executed an MoU that facilitates biomedical program interaction and creates a cohesive, synergistic and complementary interface thus expediting translational research activity.
  1. SIDRA and QBRI will jointly recruit principal investigators to assure mutual interest and compatibility of goals and will co-organize seminars, workshops or conferences
  2. SIDRA is providing office and lab space to QBRI with an estimated area between 450-500sqm where QBRI will be hosting in these facilities its personnel, which shall support SIDRA’s researchers in their basic biomedical research programs
  3. QBRI space is intermingled with SIDRA’s laboratories according to relevance and discipline to foster interactions among scientists of both institutions, thus creating a cohesive, synergistic and complementary interface thus facilitating translational research activity
Back to Top